Industry events
Scientific events, seminars and workshops
Industry Conferences and Trade Association Meetings
Investor Relations Events
Past presentations
 
2006
2005
2004
 
industry events - past presentations

Past presentations

Active Registries

Charles River Laboratories’ experience developing, implementing, and managing pregnancy registries is unsurpassed. We currently manage more pregnancy registries than any other CRO. 

Below are links to our active pregnancy registry web sites for use by both patients and physicians.

Amevive® Pregnancy Exposure Registry

Antiretroviral Pregnancy Registry

Avonex® Pregnancy Exposure Registry

Betaseron® Pregnancy Registry

Bupropion Pregnancy Registry

Exenatide Pregnancy Registry

Keppra® Pregnancy Registry

Lamotrigine Pregnancy Registry

Ribavirin Pregnancy Registry

Sumatriptan & Naratriptan PregnancyRegistry

 

 

Amevive® Pregnancy Exposure Registry

Pregnant patients exposed to Amevive® within the 8 weeks prior to conception and during the pregnancy and who are still currently pregnant may contact the registry at:

Phone: 800-811-0104

Fax: 800-800-1052

Email: registries@nc.crl.com

 

Antiretroviral Pregnancy Registry

http://www.apregistry.com

 

Avonex® Pregnancy Exposure Registry

Pregnant patients exposed to Avonex® around the time of conception and during the first trimester of pregnancy and who are still currently pregnant may contact the registry at:

Phone: 800-811-0104

Fax: 800-800-1052

Email: registries@nc.crl.com

 

Betaseron® Pregnancy Registry

Pregnant patients or healthcare providers of pregnant patients exposed to Betaseron® at the time of conception (i.e., any time from the first day of the last menstrual period) and/or during pregnancy may contact the registry at:

Phone: 800-478-7049

Fax: 800-800-1052

Email: registries@nc.crl.com

 

Bupropion Pregnancy Registry

http://pregnancyregistry.gsk.com/bupropion.html

Additional forms are provided below:

pdf 21k

Enrollment Form

pdf 8k

Patient Log

pdf 28k

Follow-up Form

 

ExenatidePregnancy Registry

Pregnant patients or health care providers of pregnant patients exposed to Byetta® (exenatide) and/or one or more other non-insulin antidiabetic medications at the time of conception (i.e., on or after the first day of the last menstrual period) may contact the registry at:

Phone: 800-633-9081

Email: registries@kendle.com

 

Keppra® Pregnancy Registry

Pregnant patients or health care providers of pregnant patients who have been exposed to Keppra® prior to conception and during pregnancy may contact the Registry at:

phone:  888-537-7734 (888-KEP-PREG) or 910-509-4970

fax:  800-800-1052 or 910-256-0637

Email:  registries@nc.crl.com

Registration forms are available for health care providers and can be downloaded from the Keppra® website. 

http://www.keppra.com

 

Lamotrigine Pregnancy Registry

http://pregnancyregistry.gsk.com/lamotrigene.html

Additional forms are provided below:

pdf 30k

Enrollment Form

pdf 9k

Patient Log

pdf 27k

Follow-up Form

 

Ribavirin Pregnancy Registry

http://www.ribavirinpregnancyregistry.com

 

Sumatriptan & Naratriptan Pregnancy Registry

http://pregnancyregistry.gsk.com/naratriptan.html

Additional forms are provided below:

pdf 22k

Enrollment Form

pdf 9k

Patient Log

pdf 29k

Follow-up Form